News

Alira Health, a global healthcare consulting and research organization, today released its fifth annual report on the state of the contract development and manufacturing organization (CDMO) market in ...
Hawthorne, NY, May 15, 2025 (GLOBE NEWSWIRE) -- In a bold step toward transforming modern medicine, OmniMD announces the launch of AI Clinicians, an intelligent clinical companion designed to elevate ...
“In conjunction with the official launch, we’re excited to announce our partnership with NovaBone Products, one of our industry’s leading innovators,” noted Yager. “This collaboration reflects our ...
GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE ® natural killer (NK) ...
As part of Elucent’s mission to lead innovation in real-time localization and surgical guidance for soft tissue excision in the treatment of cancer and other diseases, the EnVisio X1 platform sets a ...
The development of Phenesafe AI is driven by PharmAla’s drug development philosophy: ...
Dover, Delaware, May 15, 2025 (GLOBE NEWSWIRE) -- Riti, a wellness company producing dietary supplements, announced that its testosterone support product, T-Booster, has been ranked #3 on News Watch ...
Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing surges ...
SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the ...
The gross proceeds to the Company from the offering are expected to be approximately $2 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The ...
Leerink Partners and Evercore ISI are acting as joint bookrunning managers for the offering. LifeSci Capital is also acting as a bookrunning manager in the offering. Citizens Capital Markets and ...